COBRE Center on Opioids and Overdose
COBRE 阿片类药物和药物过量中心
基本信息
- 批准号:10006576
- 负责人:
- 金额:$ 237.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accidental InjuryAcuteAddressAffectAnalgesicsAreaBenefits and RisksCaringCenters for Disease Control and Prevention (U.S.)Centers of Research ExcellenceCessation of lifeClinical ResearchCollaborationsConsultationsCountryDataData Management ResourcesDisciplineDiseaseDoctor of PhilosophyEducation and OutreachEnsureEpidemicEthicsFacultyFentanylFetusFundingGoalsHealth TechnologyHeroinHospitalsImprisonmentIndividualInfrastructureInstitutionJointsKnowledgeLeadershipLinkMentorsMentorshipMethodologyMotivationMusculoskeletal PainNeonatal Abstinence SyndromeOpiate AddictionOpioidOverdosePatternPharmaceutical PreparationsPoliciesPopulationPreventionPrevention approachPublic HealthResearchResearch ActivityResearch DesignResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesRhode IslandScientistSenior ScientistServicesStrategic PlanningSurgeonTranslational ResearchUnited StatesUnited States National Institutes of HealthVehicle crashVulnerable PopulationsWorkcareercareer developmentcohortcontingency managementdata visualizationearly-career facultyeffective interventionhigh risk populationimplementation scienceinnovationmHealthmembermultidisciplinarynamed groupopioid misuseopioid overdoseopioid use disorderorganizational structureprescription opioidpreventprogramsrecruitsupport tools
项目摘要
PROJECT SUMMARY
We propose to build and sustain the Center of Biomedical Research Excellence (COBRE) on Opioids and
Overdose at Rhode Island Hospital and affiliated research institutions. The motivation for this effort lies in the
tremendous need for greater scientific understanding of the mechanisms underpinning vulnerability to opioid
use disorder and a need for more effective interventions to treat and prevent opioid misuse and overdose. We
will approach these challenges through ongoing, cooperative partnership among senior scientists and early
career investigators across several complementary disciplines. We propose a unique and innovative mentoring
strategy that, in addition to primary project advising, will provide junior faculty members with specialized
mentorship and services that empowers investigators to influence policy and practice through their research.
Moreover, we will build four interdisciplinary cores that will provide infrastructure, consultation, and additional
support services to ensure the successful career development of our Project Leaders. The long-term goal of
the Center is to develop and sustain a critical mass of investigators specializing in opioids and overdose that
benefits affected populations and enhances the competitiveness of affiliated investigators. The objective of this
proposal is to establish and build the COBRE Center and to support the research activities of junior Project
Leaders to ensure their transition to R01-funded scientists. There are two Specific Aims—one related to the
establishment of a new disease-specific research center, and one encompassing four Research Projects that
are linked by the themes of opioids and overdose. Aim 1: Establish the cores needed to develop and sustain a
thematic multidisciplinary center of research excellence on opioids and overdose. Four cores will be created to
achieve this aim: an Administrative Core, a Data and Research Methods (DRM) Core, a Translational and
Transformative (T2) Core, and a Special Populations (SP) Core. Aim 2: Support the selection, mentorship, and
career development of early career faculty Project Leaders. The four initial research projects are: Project 1:
(Beaudoin) “Informed opioid prescribing for acute musculoskeletal pain after motor vehicle collision: A support
tool for assessing risks and benefits of analgesic medications before prescribing (STAAMP),” Project 2:
(Claborn) “Prevention of Opioid Overdose following Incarceration: Leveraging Mobile Health Technology,”
Project 3: (Becker) “Contingency Management in Combination with MAT for Opioid Use Disorders,” and
Project 4: (Czynski) “Neonatal Abstinence Syndrome (NAS): Fetus to First Years.” The proposed center will
bring together an interdisciplinary group of accomplished senior scientists, promising junior investigators, and
distinguished advisors and collaborators to work closely together to establish a center of excellence in an area
of clinical research that is of critical public health importance.
项目总结
我们建议建立和维持生物医学卓越研究中心(COBRE)关于阿片类药物和
罗德岛医院及其附属研究机构服药过量。这一努力的动机在于
迫切需要对阿片类药物易感性的机制有更深入的科学了解
使用障碍和需要更有效的干预措施来治疗和预防阿片类药物滥用和过量。我们
将通过资深科学家之间持续的合作伙伴关系和早期
跨几个互补学科的职业调查员。我们提出了一种独特的、创新的指导
除了主要的项目建议外,还将为初级教员提供专门的
指导和服务,使研究人员能够通过他们的研究影响政策和实践。
此外,我们还将构建四个跨学科核心,以提供基础设施、咨询和其他
支持服务,以确保我们的项目负责人成功的职业发展。的长期目标是
该中心将发展和维持一批专门研究阿片类药物和过量用药的调查人员
使受影响的人群受益,并提高附属调查人员的竞争力。这样做的目的是
建议建立和建设科布雷中心,支持初级项目的研究活动
领导人确保他们过渡到R01资助的科学家。有两个具体的目标-一个与
建立一个新的疾病研究中心,其中一个包括四个研究项目,
由阿片类药物和过量用药这两个主题联系在一起。目标1:建立发展和维持
关于阿片类药物和过量用药的卓越研究的多学科专题中心。将创建四个核心,以
实现这一目标:管理核心、数据和研究方法(DRM)核心、翻译和
变革性(T2)核心和特殊群体(SP)核心。目标2:支持选拔、指导和
早期职业教师项目领导者的职业发展。四个初步研究项目是:项目1:
(Beaudoin):对机动车碰撞后急性肌肉骨骼疼痛的知情阿片类药物处方:一种支持
处方前止痛药风险和收益评估工具(STAAMP),“项目2:
“预防监禁后阿片类药物过量:利用移动医疗技术,”
项目3:(Becker)“阿片类药物使用障碍的应急管理与MAT相结合”,以及
项目4:(Czynski)“新生儿禁欲综合症(NAS):胎儿至一岁。”拟建的中心将
聚集了一个由有成就的资深科学家组成的跨学科小组,他们是有前途的初级调查人员,以及
杰出的顾问和合作者紧密合作,在某一领域建立卓越中心
对公共卫生具有重要意义的临床研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSIAH D RICH其他文献
JOSIAH D RICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSIAH D RICH', 18)}}的其他基金
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island
评估罗德岛州非处方丁丙诺啡的非刑事化
- 批准号:
10676209 - 财政年份:2022
- 资助金额:
$ 237.67万 - 项目类别:
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island
评估罗德岛州非处方丁丙诺啡的非刑事化
- 批准号:
10549069 - 财政年份:2022
- 资助金额:
$ 237.67万 - 项目类别:
Evaluation of Low Threshold Buprenorphine Treatment in the Context of COVID-19
COVID-19 背景下低阈值丁丙诺啡治疗的评估
- 批准号:
10358229 - 财政年份:2021
- 资助金额:
$ 237.67万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 237.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 237.67万 - 项目类别:
Standard Grant














{{item.name}}会员




